International Conference on Neurological Disorders and Stroke

This session explores the global burden of neurological disorders and disparities in access to neurological care worldwide. Topics include epidemiological trends, healthcare infrastructure challenges, and strategies for improving neurological care delivery in low-resource settings. Discussions will also address cultural considerations, socioeconomic factors, and policy initiatives impacting neurological health outcomes on a global scale. The session aims to promote international collaboration and knowledge exchange among healthcare professionals, researchers, and policymakers to address the global neurological burden effectively. By sharing best practices and innovative approaches, this session seeks to advance equitable access to quality neurological care and reduce disparities in neurological health outcomes across diverse populations.

This session addresses critical care management and acute interventions for patients with severe neurological conditions. Topics include advances in neurointensive care protocols, monitoring techniques, and therapeutic strategies for traumatic brain injury, stroke, status epilepticus, and other acute neurological emergencies. Discussions will also cover neurocritical care outcomes, prognostication models, and ethical dilemmas in intensive care settings. The session aims to enhance knowledge and skills among healthcare providers involved in the acute management of neurological emergencies, fostering collaboration between neurologists, intensivists, neurosurgeons, and emergency medicine specialists to improve patient outcomes in critical care settings.

This session focuses on promoting brain health across the lifespan and addressing neurological issues associated with aging. Topics include cognitive decline, dementia prevention strategies, lifestyle interventions, and the role of nutrition, exercise, and cognitive training in maintaining brain function. Discussions will also cover the impact of aging on neurological disorders such as Alzheimer's disease and Parkinson's disease, exploring mechanisms of neuroprotection and resilience in older adults. The session aims to highlight multidisciplinary approaches to promoting healthy brain aging, integrating perspectives from neurology, geriatrics, psychology, and public health. By sharing evidence-based strategies and research findings, this session aims to inform healthcare practices and policies aimed at supporting cognitive health and well-being in aging populations.

This interdisciplinary session examines the ethical and legal implications of advances in neuroscience and neurotechnology. Topics include neuroethics frameworks for brain research and clinical practice, ethical considerations in neuroimaging and neurogenetics, and the intersection of neuroscience and law in areas such as brain-based lie detection, neuroenhancement, and decision-making capacity. Discussions will also address ethical challenges in neuroscientific research involving vulnerable populations, consent protocols for neurointerventions, and the implications of neuroscientific evidence in legal proceedings. The session aims to foster dialogue among neuroscientists, ethicists, legal scholars, and policymakers to ensure responsible innovation and equitable access to neurotechnologies while safeguarding individual rights and autonomy.

This session showcases promising new therapies and treatment modalities for neurological disorders currently under investigation. Topics include experimental drugs, biologics, gene therapies, and stem cell-based approaches targeting neurodegenerative diseases, epilepsy, movement disorders, and more. Discussions will cover preclinical and clinical trial data, safety profiles, and efficacy outcomes of emerging therapies. Additionally, regulatory challenges, ethical considerations, and patient perspectives on novel treatments will be explored. The session aims to provide attendees with insights into the pipeline of innovative therapies in neurology, highlighting potential breakthroughs that could transform patient care in the near future.

This session focuses on the genetic underpinnings of neurodevelopmental disorders such as autism spectrum disorders, epilepsy, and intellectual disabilities. Discussions will cover recent discoveries in neurogenetics, including the identification of genetic risk factors, gene-environment interactions, and epigenetic mechanisms influencing brain development and function. Topics will also explore advances in genomic technologies, including next-generation sequencing and genome-wide association studies (GWAS), and their implications for diagnosis, prognostication, and personalized therapies in neurology. The session aims to foster collaboration between geneticists, neuroscientists, and clinicians to accelerate the translation of genetic research findings into clinical practice, ultimately improving outcomes for individuals affected by neurodevelopmental disorders.

Focused on stroke prevention strategies and rehabilitation techniques, this session addresses the continuum of care from risk reduction to recovery. Discussions will encompass innovations in stroke prevention through lifestyle modifications, pharmacotherapy, and interventional procedures. Rehabilitation topics will include advances in neurorehabilitation therapies, robotics, and assistive technologies aimed at optimizing recovery and improving functional outcomes post-stroke. The session aims to explore multidisciplinary approaches in stroke care, integrating perspectives from neurologists, rehabilitation specialists, physiotherapists, and psychologists. By highlighting evidence-based practices and emerging interventions, this session seeks to improve stroke management strategies globally and enhance the quality of life for stroke survivors.

This session highlights recent breakthroughs in neuroimaging techniques and their applications in diagnosing and understanding neurological disorders. Discussions will cover advancements in functional MRI (fMRI), diffusion tensor imaging (DTI), positron emission tomography (PET), and magnetoencephalography (MEG), among others. Topics include the role of neuroimaging in early detection, disease progression monitoring, and treatment response assessment across various neurological conditions. Additionally, emerging technologies such as advanced image processing algorithms and machine learning approaches will be explored for their potential to enhance diagnostic accuracy and clinical decision-making in neurology. This session aims to foster collaboration among neuroimaging experts, clinicians, and researchers to accelerate the translation of imaging innovations into clinical practice.

Precision medicine is revolutionizing healthcare by tailoring treatment to individual genetic, environmental, and lifestyle factors. This session will showcase cutting-edge advancements in applying precision medicine principles to neurological disorders. Topics include genomic profiling for personalized diagnostics and therapeutics, pharmacogenomics in neuropharmacology, and the role of biomarkers in disease stratification and treatment response prediction. Discussions will also address ethical considerations, implementation challenges, and the potential impact of precision medicine on patient outcomes and healthcare delivery. Attendees will gain insights into the future of neurology where treatments are customized to each patient's unique profile, promising more effective and personalized care strategies.

This session focuses on the intricate relationship between neuroinflammation and neurodegenerative diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. Discussions will cover the latest research on inflammatory processes in the central nervous system, including the role of microglia and astrocytes. Insights into how inflammation contributes to neuronal loss and disease progression will be explored, along with potential therapeutic targets to modulate these processes. The session aims to advance our understanding of the immune response in neurological disorders, paving the way for novel treatment strategies and neuroprotective interventions.